Table 1B: Demographic, clinical and histological characteristics of patients with Langerhans cell histiocytosis in vulva
Table 1B: Demographic, clinical and histological characteristics of patients with Langerhans cell histiocytosis in vulva |
||||||||
Author |
Age (Years) |
Type of skin lesion |
Affected site |
Inmunohistochemistry exam |
Systemic commitment |
Treatment |
Response |
Outcome (months) |
Triantafyllidou et al[1] |
52 |
Papule |
Labia minora |
NI |
No |
Local excision |
CR |
NED (10) |
Hwang C et al[2] |
1 |
Papule |
Labia majora |
S100 (+) CD1a (+) |
No |
Topical corticosteroid |
NI |
NI |
Hussein M.R.A [3] |
8 |
Papule |
Vulva |
S100 (+) CD1a (+) |
No |
NI |
NI |
NI |
Pan Z et al [4] |
49 |
Ulcer |
Clitoris |
S100 (+) CD1a (+) HMB45 (-) |
No |
RT |
CR |
NED (5) |
Bongiorno M et al[5] |
32 |
Ulcer |
Vulva |
S100 (+) CD1a (+) |
Osseous/Pituitary/Lungs |
CT(Vinblastin) + PREDNIS |
CR |
NED (22) |
Tran D.T et al[6] |
19 |
Papule |
Vulva |
S100 (-) CD1a (-) CD68 (+) |
Osseous/Pituitary |
Clobetasol + CT(Vincristin/cytosine-arabinoside)+PREDNIS + MTX |
NI |
NI |
Beneder C. et al[7] |
49 |
Papule |
Vulva |
S100 (+) CD1a (+) |
No |
Local excision + RT |
CR |
NED (51) |
Dewan M et al[8] |
35 |
Ulcer |
Vulva |
S100 (+) Birbeck granules (+) |
No |
Local excision |
NI |
NI |
Liu Y.H et al[9] |
32 |
Ulcer |
Labia majora |
S 100(+) CD1a (+) CD68(+) |
Osseous/Pituitary/Gingiva |
CT (Ciclophosphamide + etoposide) + PREDNIS |
NI |
NI |
Mottl H et al[10] |
16 |
Vesicle |
Vulva |
S100 (+) CD1a (+) |
No |
Local excision + CT (Vinblastin) + PREDNIS + Cladribine |
CR |
NED (18) |
Mlyncek M et al[11] |
63 |
Ulcer |
Vulva |
S100 (+) CD1a (+) |
No |
Radical vulvectomy |
CR |
NED (12) |
Venizelos I.D et al[12] |
64 |
Ulcer |
Labia minora |
S100 (+) CD1a (+) Vimentin (+) |
No |
Partial Vulvectomy + RT |
CR |
NED (22) |
Ishigaki H et al[13] |
65 |
Ulcer |
Vulva |
S100 (+) CD1a (+), Birbeck granules |
No |
Local excision |
CR |
NED (12) |
Padula A et al [14] |
31 |
Nodules/ulcer |
Labia minora |
S-100 (+) CD1A (+) |
No |
Radical Vulvectomy + RT |
CR |
NED (19) |
|
52 |
Ulcer |
Clitoris |
S-100 (+) CD1A (+) |
Osseous |
RT + CT (Vinblastin + 6 mercaptopurine) |
NI |
NI |
Powell J.L[15] |
2 |
NI |
NI |
NI |
Osseous/Bone marrow/Spleen |
Local excision + CT(Vinblastin) |
CR |
NED (180) |
Dietrich J.E et al[16] |
41 |
Ulcer |
Vulva |
NI |
Pituitary |
Local excision + RT + MTX |
NI |
NI |
|
29 |
NI |
Vulva |
NI |
No |
Radical vulvectomy +RT+ PREDNIS + Clobetasol cream 0.05% |
NR |
REC (NI) |
Santillan A et al[17] |
33 |
Nodules |
Vulva |
S100 (+) CD1a (+) HMB45 (-) |
No |
Radical Vulvectomy + RT + Thalidomide |
CR |
NED(12) |
Ruiz A. M.A et al[18] |
49 |
Nodules |
Vulva |
S-100 (+) CD1a |
No |
Thalidomide + clobetasol |
NR? |
NI |
Rizvi R.M et al[19] |
41 |
Ulcer |
Labia minora |
S-100 (+), CD-68 (+) |
No |
Simple vulvectomy |
CR |
NED (1.5) |
Solano T et al[20] |
40 |
Ulcer |
Vulva |
S-100 (+), CD1a (+) |
No |
Local excision + QT (Vincristina) |
CR |
NED (18) |
Prignano F et al[21] |
64 |
Ulcer |
Vulva |
CD1a (+) Birbeck granules |
Pituitary |
CT (Vinblastin) |
NI |
NI |
Khawali C. et al[22] |
31 |
Ulcer |
Vulva |
NI |
Pituitary/hepatic |
CT + hormonal replacement (desmopressin + levothyroxine) |
NI |
NI |
Savell V. et al[23] |
76 |
NI |
Vulva |
NI |
No |
CT (Vinblastin + Vincristin) |
CR |
NED (9) |
Takata M. et al[24] |
62 |
Ulcer |
Vulva |
CD1a, CD4 y DLA-DR (+) S100(+), Vimentin (+), Birbeck granules |
Osseous |
Local excision + RT |
NI |
NI |
Voelklein K. et al[25] |
36 |
Ulcer |
Vulva |
S100 (+) |
No |
RT |
NI |
NI |
Wong K.K et al[26] |
13 |
Ulcer |
Vulva |
S-100 (+) |
Osseous/ Pituitary |
CT (Vincristine) + PREDNIS |
NI |
REC (NI) |
Axiotis C. A. et al[27] |
85 |
NI |
Vulva |
NI |
No |
Topical corticosteroid |
NR |
REC (NI) |
Sang Y.H [28] |
26 |
Ulcer |
Labia majora |
NI |
Pituitary |
RT |
CR |
REC (6) |
Otis C.N et al[29] |
2 |
Ulcer |
Vulva |
S100 (+) |
Osseous |
CT (Vinblastin) |
NR |
REC (NI) |
NED: No evidence of disease, NI: No information; NR: No response; MTX: methotrexate, REC: Recurrent; CR: complete response CT: Chemotherapy; PREDNIS: Prednisolone; RT: Radiotherapy; MTX: Methotrexate |
[1]Triantafyllidou O., Giannakopoulos K., Pergialiotis V., Simou M., Lagkadas A., Alexandrou P. Pure vulvar Langerhans cell histiocytosis: A case report and literature review. European Journal of Gynaecological Oncology 2009 30:6 (691-694).
[2] Hwang C, Kim YJ, Seo YJ, Park JK, Lee JH, Lee Y. Isolated Langerhans Cell Histiocytosis of the Vulva in an Infant. PediatrDermatol 2009(6):751
[3] Hussein MRA. Skin-limited Langerhans' cell histiocytosis in children. Cancer Invest 2009 06;27(5):504-511
[4] Pan Z, Sharma S, Sharma P. Primary Langerhans cell histiocytosis of the vulva: Report of a case and brief review of the literature. Indian Journal of Pathology and Microbiology 2009(1)
[5]Bongiorno MR, Pistone G, de Giorgi V, Aricò M. Clinical and immunohistochemical evaluation of the vulvar Langerhans cell histiocytosis. Dermatologic Therapy 2008 11/02;21:S15-S20
[6] Tran DT, Wolgamot GM, Olerud J, Hurst S, Argenyi Z. An 'eruptive' variant of juvenile xanthogranuloma associated with langerhans cell histiocytosis. J CutanPathol 2008 10;35 Suppl 1:50-54
[7]Beneder C, Kuhn A, ImObersteg J, Beer K, Fleischmann A, Mueller MD. Isolated Langerhans cell histiocytosis of the vulva: a case report and review of the literature. Gynecological Surgery 2008(2):165
[8]Dewan M, Al-Ghamdi A, Zahrani MB. Lessons to be learned--Langerhans' cell histiocytosis. J R SocPromot Health 2008 01;128(1):41-46
[9] Liu, Y.H, Fang K, Fan XH. Langerhans' cell histiocytosis with multisystem involvement in an adult. ClinExpDermatol 2007 / 11 / 01 /;32(6):765-768
[10]Mottl H, Rob L, Stary J, Kodet R, Drahokoupilova E. Langerhans cell histiocytosis of vulva in adolescent. International Journal of Gynecological Cancer 2007(2):520
[11]Mlynček M, Uharček P, Durčanský D. Vulvar Langerhans’ cell histiocytosis: a case report. ActaObstetGynecolScand 2006 06/01; 2018/09;85(6):753-755
[12] Venizelos ID, Mandala E, Tatsiou ZA, Acholos V, Goutzioulis M. Primary langerhans cell histiocytosis of the vulva. Int J GynecolPathol 2006 01;25(1):48-51
[13]Ishigaki H, Hatta N, Yamada M, Orito H, Takehara K. Localised vulva Langerhans cell histiocytosis. Eur J Dermatol. 2004 Nov-Dec;14(6) 412-414.
[14]Padula A, Medeiros LJ, Silva EG, Deavers MT. Isolated vulvar Langerhans cell histiocytosis: report of two cases. Int J GynecolPathol 2004 07;23(3):278-283
[15] Powell, J.L., Otis CN, Ramirez, P.T. Commenting on "vulvar langerhans cell histocytosis: A case report and review of the literature" by Santillan et al. 91:241-246 [2] (multiple letters). GynecolOncol 2004 / 01 / 01 /;93(3):719
[16] Dietrich JE, Edwards C, Laucirica R, Kaufman RH. Langerhans cell histiocytosis of the vulva: two case reports. J Low Genit Tract Dis 2004 04;8(2):147-149
[17]Santillan A, Montero AJ, Kavanagh JJ, Liu J, Ramirez PT. Vulvar Langerhans cell histiocytosis: a case report and review of the literature. GynecolOncol 2003 10;91(1):241-246
[18] Ruiz Beguerie, J. Fernández, J. Stringa MF, Anaya, J. Vulvar Langerhans cell histiocytosis and thalidomide: an effective treatment option. Int J Dermatol 2017 / 03 / 01 /;56(3):324-326
[19] Rizvi R.M., Nasreen C., Jafri N. Histiocytosis X of the vulva. JPMA. The Journal of the Pakistan Medical Association 2002 52:9 (430)
[20] Solano T, España A, Sola J., López G. Langerhans' cell histiocytosis on the vulva. Gynecologic Oncology 2000 78:2 (251-254)
[21]Prignano F, Domenici L, Carli P, Pimpinelli N, Romagnoli P. Langerhans cell histiocytosis of the vulva: an ultrastructural study. UltrastructPathol 1999 03/19;23(2):127-132
[22]Khawali C., Silva M.R.D., Faiçal S. Hypothalamic Diabetes Insipidus and panhypopituitarism due to Langerhans cell histiocytosis in an adult. Endocrinologist 1999 9:1 (61-63)
[23]Savell V, Hanna R, Benda JA, Argenyi ZB. Histiocytosis X of the vulva with a confusing clinical and pathologic presentation. A case report. J Reprod Med. 1995 Apr;40(4) 323-326.
[24]Takata M, Taniguchi A, Imai T, Hirone T, Nonomura A, Fukui Y. An Adult Case of Histiocytosis X with a Vulvar Ulcer and Multiple Bone Lesions. The Journal of Dermatology 1994 04/01; 2019/03;21(4):259-263
[25]Voelklein K., Horny H. Prymary Langerhans Cell Histiocytosis of the vulva. Gynecol. Obstet. Invest. 1993; 36(3): 189-90.
[26] Wong K.K., Lin H.P., Loo L.M. Histiocytosis X and vulvar ulceration International Journal of Gynecology and Obstetrics 1992 39:2 (131-134)
[27]Axiotis C., Merino M., Dura y P. Langerhans cell Histiocytosis of the female genital trae t. Cancer. 1991; 67: 1650-1660.
[28] Sang Y.H., Choi I.C., Jun J.B., Kim D.W., and Chung S.L. Histiocytosis-X with chronic weeping ulcers in the anogenital areas. Annals of Dermatology 1990 2:2 (128-131)
[29] Otis C.N., Fischer R.A., Johnson N., Kelleher J.F., Powell J.L. Histiocytosis X of the vulva: A case report and review of the literature Obstetrics and Gynecology 1990 75:3 II (555-558)